Clinical studies in the association with retina vitreous disease and intraocular cytokine

Clinical studies in the association with retina vitreous disease and intraocular cytokine - Clinical studies in the association with retina vitreous disease and intraocular cytokine

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003376

Enrollment

Registered

2010-03-25

Start date

2009-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

retina vitreous disease

Interventions

vitrectomy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. clinically detectable diffuse macular edema or cystoid macular edema that had persisted for more than 3 months 2. best-corrected visual acuity worse than 20/40 3. persistence of macular edema despite retinal photocoagulation

Exclusion criteria

Exclusion criteria: 1. previous ocular or vitreous injection of anti-VEGF agent 2. diabetic retinopathy 3. history of ocular inflammation

Design outcomes

Primary

Measure	Time frame
Level of intraocular cytokines	—

Countries

Japan

Contacts

Public ContactHidetaka Noma

Yachiyo Medical Center, Tokyo Womens Medical University Department of Ophthalmology

nomahide@tymc.twmu.ac.jp047-450-6000

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026